| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2017 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 35,3 M € | +0.8% | 35,0 M € | -17.4% | 42,4 M € | +22.8% | 34,6 M € | +4.4% | 33,1 M € | +9.0% | 30,4 M € | +13.2% | 26,8 M € | — | — | — | ||||
| Gross margin | — | — | — | — | — | — | — | 2,4 M € | +856.1% | 255,9 k € | +985.9% | 23,6 k € | ||||||||
| EBITDA | 2,8 M € | -31.9% | 4,1 M € | +19.6% | 3,4 M € | +655.1% | 452,8 k € | -88.1% | 3,8 M € | -18.3% | 4,7 M € | +92.7% | 2,4 M € | +1603.5% | -161,4 k € | +71.8% | -571,7 k € | +44.8% | -1,0 M € | |
| Operating profit | -13,7 k € | -101.8% | 748,1 k € | -13.1% | 860,4 k € | +148.6% | -1,8 M € | -373.9% | 645,7 k € | -62.3% | 1,7 M € | +333.9% | -732,2 k € | +59.8% | -1,8 M € | -47.8% | -1,2 M € | +46.8% | -2,3 M € | |
| Profit/loss | -14,4 M € | -37.1% | -10,5 M € | -66.9% | -6,3 M € | -37.4% | -4,6 M € | -76.1% | -2,6 M € | -138.4% | -1,1 M € | +69.3% | -3,5 M € | +5.3% | -3,7 M € | -86.2% | -2,0 M € | +39.5% | -3,3 M € | |
| Equity | -1,6 M € | -112.1% | 12,8 M € | -31.4% | 18,7 M € | +63.2% | 11,4 M € | +45.7% | 7,8 M € | +202.2% | -7,7 M € | -16.5% | -6,6 M € | -115.7% | -3,1 M € | -31.7% | -2,3 M € | -27.8% | -1,8 M € | |
| Total assets | 265,9 M € | +23.8% | 214,7 M € | +23.4% | 173,9 M € | +40.2% | 124,0 M € | +41.5% | 87,7 M € | +59.3% | 55,1 M € | +2.7% | 53,6 M € | +15.7% | 46,3 M € | +142.2% | 19,1 M € | +113.0% | 9,0 M € | |
| Cash | 395,8 k € | -88.9% | 3,6 M € | -80.2% | 18,0 M € | +172.6% | 6,6 M € | -9.9% | 7,3 M € | +294.0% | 1,9 M € | -28.9% | 2,6 M € | +429.0% | 493,8 k € | -77.7% | 2,2 M € | +453.8% | 399,2 k € | |
| Debts | 263,3 M € | +32.4% | 198,8 M € | +29.9% | 153,1 M € | +37.3% | 111,5 M € | +40.9% | 79,1 M € | +28.3% | 61,7 M € | +4.2% | 59,2 M € | +22.8% | 48,2 M € | +128.3% | 21,1 M € | +102.9% | 10,4 M € | |
| Staff | 37 | 42,1 | 45,6 | 38,1 | 43,5 | 42 | 41,8 | 31,9 | 11,3 | 10,9 | ||||||||||
Public limited company · Gent · incorporated on 28/10/2015 · 37,0 ETP
Public limited company loss-making in the latest fiscal year. Cash position declining (-88.9%).
Solid counterparty for a standard engagement.
Ceres Pharma is a Public limited company incorporated in 2015. Its main activity is: Manufacture of other food products n.e.c.. Its registered office is in Gent. It employs on average 37,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette